Navigation Links
Symphony PCS

ProductsSymphony PCS
Company DePuy Orthopaedics, Inc.
Item Symphony PCS
Features Low blood volume. The Symphony II PCS can produce consistently high levels of platelet concentrate from as little as 55-110 ml of the patient's blood. Permits multiple runs on a single patient, if necessary. Automated system captures platelets available in whole blood, assuring a consistently high level of platelet concentrate. Consistently yields three to six times the baseline level of platelets. Growth factors found in platelets - PDGF, TGF-, EGF, and VEGF - are also increased three to six times. Quick, automated system makes platelet concentrate available in less than 15 minutes, eliminating intraoperative delays.
Description Symphony Platelet Concentrate System is a point-of-care system designed for the rapid preparation of Platelet Concentrate (also referred to as Platelet Rich Plasma - PRP) and Platelet Poor Plasma (PPP) from a small sample of blood. The Symphony PCS concentrates the body's natural growth factors, which are found in the platelets. The platelet concentrate can be mixed with autograft and allograft bone grafting materials prior to application to an orthopedic surgical site as deemed necessary by the clinical use requirements. The Symphony PCS produces autologous platelet concentrate containing viable platelets with a full compliment of associated growth factors.
Info DePuy Orthopaedics, Inc.
Customer Service: (800) 366-8143
Web site: http://www.jnjgateway.com/home.jhtml?loc=USENG&page=viewContent&contentId=09008b9880772d01

Related medicine products :

1. Symphony I/C Graft Chambers
2. Symphony II
3. Symphony SR 2250
4. Symphony DR 2550
5. TCS Symphony
6. MAGNETOM Symphony
...
... combination of Penicillin, Steptomycin, and Amphotericin ... forms of cell culture contamination; bacteria ... and fungi; when used at a ... solution is a combination of all ...
All BioWhittaker Cell Culture Reagent and Buffer products are manufactured in accordance with cGMP regulations and are cell culture tested to assure compatibility. , Typical Properties, Sterility : ...
... Appearance/Form: White to buff-colored powder Activity: >=590g of gentamicin/mg ... Passes tests Limit of Methanol: Specific Rotation (25C): ... (4%, H 2 O): 3.5 to 5.5 Loss on ... 1 : 25-50% C 2 + C 2a ...
Medicine Products:
(Date:10/13/2017)... ... , ... PurhealthRX , a leading Health and Nutrition Company, is announcing ... full spectrum CBD oil will revolutionize the rapidly growing CBD market by reducing the ... incorporated into liquid products, while reducing costs to end users. , The team of ...
(Date:10/13/2017)... ... ... The Visiting Nurse Association (VNA) of Somerset Hills is proud to host ... items from across the nation, this holiday-themed event will raise funds and awareness for ... The boutique will be open Saturday, November 4 (10:00 a.m. – 5:00 p.m.) ...
(Date:10/13/2017)... ... 13, 2017 , ... Coveros, a leader in agile coaching ... contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile ... of Agile methodologies in a consistent and high value manner across CMS programs. ...
(Date:10/12/2017)... New Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... fitness centers in the U.S., announced today its plans to open a flagship location ... club will occupy the former Rooms To Go store next to Office Depot in ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
Breaking Medicine News(10 mins):
(Date:9/22/2017)... 2017 AVACEN Medical (AVACEN) announced that its ... helping those with the widespread pain associated with fibromyalgia ... in Essex, England commented, "I ... experiencing no sleep at all, tremendous pain, with every ... recommend [the AVACEN 100] enough, how this has and ...
(Date:9/18/2017)... , Sept. 18, 2017 EpiVax, ... of bioinformatics and immune engineering, today announced ... influenza A (H7N9) vaccine. ... to seasonal influenza and presents a challenge ... prior exposure to be effective. Using state-of-the-art ...
(Date:9/12/2017)... 2017  ValGenesis Inc., the global leader in ... to announce the appointment of Dr. Ajaz ... of Directors and Chairman of Advisory Board beginning ... companies to manage their entire validation lifecycle process ... this process. Furthermore, ValGenesis VLMS enables rigorous compliance, ...
Breaking Medicine Technology: